Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies.
Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies.
复制标题
DOI:
10.1371/journal.pgen.1007142
复制
发表时间:
2017-12
期刊:
影响因子:
4.5
通讯作者:
Zhang ZD
中科院分区:
文献类型:
--
作者:
Lin JR;Zhang Q;Cai Y;Morrow BE;Zhang ZD
Rare variants of major effect play an important role in human complex diseases and can be discovered by sequencing-based genome-wide association studies. Here, we introduce an integrated approach that combines the rare variant association test with gene network and phenotype information to identify risk genes implicated by rare variants for human complex diseases. Our data integration method follows a 'discovery-driven' strategy without relying on prior knowledge about the disease and thus maintains the unbiased character of genome-wide association studies. Simulations reveal that our method can outperform a widely-used rare variant association test method by 2 to 3 times. In a case study of a small disease cohort, we uncovered putative risk genes and the corresponding rare variants that may act as genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome patients. These variants were missed by a conventional approach that relied on the rare variant association test alone. Case-control sequencing studies are a promising design to uncover risk genes of human complex diseases implicated by rare variants. The recent development of different types of rare variant association tests has improved the statistical power to identify disease genes that harbor risk rare variants. However, none of the recent sequencing-based genome-wide association studies identified robust disease association of rare variants or genes based on them. Due to limited sample sizes that can be feasibly achieved in real applications, current rare variant association tests can only generate marginal association signals for most risk genes. Here we proposed an integrated method that combined association signals with orthogonal biological evidence to uncover risk genes in sequencing studies. Designed to address the lack-of-power issue, our method was shown to effectively uncover risk genes with marginal association signals in data simulation. Indeed, in a real application demonstrated in our case study our method disclosed important risk genes of congenital heart disease in 22q11.2 deletion syndrome that were missed by the previous study.
登录
查看更多内容
影响因子:
4.6
作者:
Han H;Shim H;Shin D;Shim JE;Ko Y;Shin J;Kim H;Cho A;Kim E;Lee T;Kim H;Kim K;Yang S;Bae D;Yun A;Kim S;Kim CY;Cho HJ;Kang B;Shin S;Lee I
通讯作者:
Lee I
影响因子:
3.7
作者:
Gillis J;Pavlidis P
通讯作者:
Pavlidis P
影响因子:
4.5
作者:
Liu L;Sabo A;Neale BM;Nagaswamy U;Stevens C;Lim E;Bodea CA;Muzny D;Reid JG;Banks E;Coon H;Depristo M;Dinh H;Fennel T;Flannick J;Gabriel S;Garimella K;Gross S;Hawes A;Lewis L;Makarov V;Maguire J;Newsham I;Poplin R;Ripke S;Shakir K;Samocha KE;Wu Y;Boerwinkle E;Buxbaum JD;Cook EH Jr;Devlin B;Schellenberg GD;Sutcliffe JS;Daly MJ;Gibbs RA;Roeder K
通讯作者:
Roeder K
影响因子:
48
作者:
Li T;Wernersson R;Hansen RB;Horn H;Mercer J;Slodkowicz G;Workman CT;Rigina O;Rapacki K;Stærfeldt HH;Brunak S;Jensen TS;Lage K
通讯作者:
Lage K
影响因子:
30.8
作者:
Kircher, Martin;Witten, Daniela M.;Jain, Preti;O'Roak, Brian J.;Cooper, Gregory M.;Shendure, Jay
通讯作者:
Shendure, Jay